.AstraZeneca has actually discussed a very early consider the performance of its internal antibody-d...
.After announcing a phase 3 launch based upon good midstage end results, iTeos and GSK are actually ...
.The FDA should be actually more open and collaborative to release a rise in commendations of rare i...
.It is actually an uncommonly active Friday for biotech IPOs, along with Zenas BioPharma, MBX and Bi...
.Atea Pharmaceuticals' antiviral has stopped working an additional COVID-19 trial, but the biotech s...
.Neurocrine Biosciences' schizophrenia course pivot has actually neglected. The biotech was actually...
.Sanofi has actually made an overdue entry to the radioligand gathering, spending one hundred millio...
.After F2G's initial attempt to get a new course of antifungal to market was actually wrecked due to...
.Moderna has promised to cut R&D costs through $1.1 billion through 2027. The choice to retract t...
.Only four months after Sanofi wager $80 million in upfront cash on Fulcrum Rehabs' losmapimod, the ...